Christine Favre
6Patents
3h-index
4Co-inventors
46Inventor score
Filing activity: Jun 11, 2007 → May 21, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8921322B2 | Use of at least one botulinum neurotoxin for treating the pain induced by therapeutic treatments for the AIDS virus | Emerging Cross-Sectional Technologies | 10 | Active |
| US8273359B2 | Therapeutic use of at least one botulinum neurotoxin in the treatment of pain induced by at least one anti-neoplastic agent | Human Necessities | 8 | Active |
| US9080220B2 | Simultaneous, separate or sequential therapeutic use of at least one botulinum neurotoxin and of at least one opiate derivative | Chemistry; Metallurgy | 4 | Active |
| US8784841B2 | Therapeutic use of at least one botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy | Human Necessities | 3 | Active |
| US11975055B2 | Suppression of bone cancer-induced allodynia | Chemistry; Metallurgy | 0 | Active |
| US9259458B2 | Therapeutic use of at least one botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.